Dr. Citrome is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11 Medical Park Drive, Suite 102
Pomona, NY 10970Phone+1 914-672-2692
Summary
- Dr. Citrome is Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College in Valhalla, New York, and also presently Adjunct Professor at the Northwestern Feinberg School of Medicine in Chicago, Illinois. Dr. Citrome was the founding Director of the Clinical Research and Evaluation Facility at the Nathan S. Kline Institute for Psychiatric Research in Orangeburg, New York, and after about two decades of government service as a researcher in the psychopharmacological treatment of severe mental disorders, Dr. Citrome is currently engaged as a consultant in clinical trial design and interpretation, and remains clinically active providing assistance to patients and their families through the Assertive Community Treatment program operated by the Mental Health Association of Rockland County. Dr. Citrome is a member of the Board of Directors of the American Society of Clinical Psychopharmacology and the Immediate Past-President. Main areas of interest include schizophrenia, bipolar disorder and major depressive disorder. He is a frequent lecturer on the quantitative assessment of clinical trial results using the evidence-based medicine metrics of number needed to treat and number needed to harm. Dr. Citrome is the author or co-author of over 600 research reports, reviews, and book chapters in the scientific literature, is Editor-in-Chief of Current Medical Research and Opinion (CMRO) published by Taylor & Francis, is on the editorial board of 11 different medical journals, Editor Emeritus at the International Journal of Clinical Practice and where he served as Editor-in-Chief from 2013 through 2019, reviews for over 75 other journals, and has lectured extensively throughout the USA, Canada, Europe, and Asia.
Education & Training
- NYU Grossman School of MedicineChief Residency, Psychiatry, 1986 - 1987
- NYU Grossman School of MedicineResidency, Psychiatry, 1983 - 1987
- NYU Grossman School of MedicineResidency, Psychiatry, 1983 - 1986
- McGill University Faculty of MedicineClass of 1983
Certifications & Licensure
- NY State Medical License 1987 - 2026
- NJ State Medical License 1986 - 2015
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder Start of enrollment: 2004 Dec 01
- Risperidone Alone Vs. Risperidone Plus Valproate in the Treatment of Patients With Schizophrenia and Hostility Start of enrollment: 1999 Sep 01
Publications & Presentations
PubMed
- 1 citationsEfficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials.Inder Kaul, Sharon Sawchak, Amy Claxton, Colin Sauder, Howard H Hassman
Schizophrenia. 2024-11-02 - What to expect in 2024: important health economics and outcomes research (HEOR) trends.Ivo Abraham, Mickael Hiligsmann, Kenneth K C Lee, Leslie Citrome, Giorgio L Colombo
Expert Review of Pharmacoeconomics & Outcomes Research. 2024-11-01 - Preferences for attributes of oral antipsychotic treatments: results from a discrete-choice experiment in respondents with schizophrenia or bipolar I disorder.Michael J Doane, Marco Boeri, Caroline Vass, Cooper Bussberg, Hemangi R Panchmatia
BMC Psychiatry. 2024-09-10
Press Mentions
- How to Recognize Tardive DyskinesiaOctober 3rd, 2024
- FDA Approves First New Drug for Schizophrenia in More Than 30 YearsSeptember 27th, 2024
- Teva to Present Latest Research from Neurology Portfolio at the 2022 American Psychiatric Association Annual MeetingMay 17th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: